Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Nausea 1Inflammation 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × ginger extract × Clear all
NCT00064272 2016-10-21

IRB 2003-551

University of Michigan Rogel Cancer Center

Phase 2 Completed
180 enrolled

Nausea, Vomiting

NCT01344538 2016-08-11

Ginger for Colorectal Cancer Prevention

University of Michigan

Phase 2 Completed
30 enrolled 5 charts
Gastrointestinal

Inflammation, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡